Grow Your Own Hip Replacement, Study Says

Marie A. Kern — Wed, 13 Feb 2013 01:53:43 +0000

Metal-on-metal hip implants have caused such a stir in the medical field. With complaints about its complications and unknown risks, these hip prostheses certainly put patients in a dangerous situation. These stimulated affected patients to file hip recall lawsuits, for instance, Stryker hip recall lawsuit.

But a new research conducted by the University of Edinburg and University of Southampton may enable you to probably grow your own hip.

This is just the type of research that is needed by millions suffering from hip pain or osteoarthritis. If this will push through, there will be lesser demand on metal-on-metal hip implants; therefore, it is leading to reduced cases of people afflicted with its adverse effects.

In the United Kingdom alone, there are about 300,000 fragility structures in a year, while around 14,000 people die because of hip fractures.

The researchers in this study are trying to make an implant which is made out of a plastic material that would aid in stimulating a new bone to grow, and once the structure is adequately strong, the implant would degrade away.

It is in a scaffold where stem cells fasten themselves and they will eventually turn into bone cells rather than blood cells.
Currently, the research is still being tested on animals as well as on human tissue.

Sources:
dailymail.co.uk/news/article-2276206/The-grow-hip-replacements-make-new-bone-degrade-away.html?ito=feeds-newsxml#axzz2Kan1iFHx

The post Grow Your Own Hip Replacement, Study Says appeared first on Simbree.

Stryker Corporation to Acquire Trauson for $764 Million

Marie A. Kern — Tue, 29 Jan 2013 15:46:14 +0000

One of the leading medical technology companies, Stryker Corporation, is acquiring orthopedic device manufacturer Trauson Holdings Co. for $764 million to develop its industry in China, media reports say. The Stryker Rejuvenate hip replacement recall faced by the medical equipment giant has not stopped them from expanding their company globally.

Trauson Holdings was established in December 2002 by its chairman and chief executive officer, Mr.Qian Fuqing, who is one of the pioneers in China’s orthopedic industry. The company’s 2011 sales were almost $60 million.

“With its research and development expertise, manufacturing capabilities and strength of its distribution network, Trauson is a compelling opportunity for Stryker to drive growth in China and other emerging markets for years to come,” says Kevin Lobo, Stryker President and CEO.

Trauson’s largest shareholder, the Luna Group, has settled to grant 61.7 percent of the Trauson shares toward the offer, according to Stryker. The transaction is scheduled to close by the end of the second quarter of 2013.

Stryker reported last week its fourth-quarter and full-year revenue that exceeded Wall Street’s presumptions. The Kalamazoo, Michigan-based company also escalated the low end of its full-year-attuned income prediction to some extent and gave a 2013 revenue standpoint above market analysts’ appraisals.

Sources:
reuters.com/article/2013/01/17/us-trauson-offer-idUSBRE90G0HZ20130117
chinadaily.com.cn/hkedition/2013-01/19/content_16142098.htm

The post Stryker Corporation to Acquire Trauson for $764 Million appeared first on Simbree.